SAI MedPartners, a consultancy providing insights and analytics to the pharmaceutical, biotechnology and medical device industries and a portfolio company of Northlane Capital Partners, has bought Fulcrum Research Group.
Fulcrum, founded in 2010 and based in Waltham, Mass., is a market research consulting firm focused on the healthcare and biopharmaceuticals markets. The firm designs customized market research through physician and patient interviews and surveys to provide insights to its clients. Specific areas of focus for Fulcrum include analysis of market dynamics, product positioning and the patient journey, among others. The firm’s leadership, including founders Erik Coats, Kelly Marino and Lucy Robin, will remain in place following the transaction.
“Fulcrum complements SAI’s core competitive intelligence expertise and enhances our value proposition as a full-service decision support partner to the pharmaceutical and biotech sectors,” states Erik Nordhoy, founder and CEO of SAI.